Yarrow Bioscience, Inc. YARW

US Biotechnology

$15.28 ▼ -3.23% ($-0.51)

⬇️ Below Yest. Low 🎈 Low Float 🎢 High Beta

Open $16.79

Prev Close $15.79

Day Range $14.80 – $17.82

52W Range $12.39 – $44.28

Market Cap $187.81M

EPS (TTM) $-21.85

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2018-01-25
Shares Out.	9,440,000
Website	yarrowbioscience.com ↗
Phone	18007757936

About Yarrow Bioscience, Inc.

Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.

Yarrow Bioscience, Inc. is a publicly traded company under the ticker symbol YARW on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.